Figure 5. Early restriction of EBV by human CD56brightNKG2A+ NK cells over time.

Potency of CD56^brightNKG2A⁺ mediated EBV restriction at different time points in flow sorted B cell differentiation stages compared to effects of CD56^brightNKG2A⁻ NK cells. Data represent four independent experiments, with a total of 8 donors. All error bars represent SEM. p values depicted were calculated with two-tailed student's t test.